E2F1 and non-small cell lung carcinoma: Mechanistically, we found that ANKRD22 affected cell proliferation and the cell cycle by transcriptional up-regulation of E2F1, and the correlation between ANKRD22 and E2F1 expression was significantly positive in NSCLC tissues.